Eli Lilly LLY0.50%increase; green up pointing triangle said its next generation weight-loss drug retatrutide helped people lose up to 28.7% of their body weight after more than a year of treatment, ...

A new experimental scalp treatment called clascoterone has shown strong results in helping reduce male-pattern hair loss (also known as androgenetic alopecia, or AGA). Experts call the results ...

There’s rarely good news about Alzheimer’s disease, but a failed study may open the door to more research about vascular dementia. Novo Nordisk NVO announced Monday that its oral GLP-1 called Rybelsus ...

#3d #3danimation #satisfying #asmr #minecraft #minecraftshorts #3dart #blender Medicare coverage is changing next month Rubio directs diplomats to return to using Times New Roman, undoing Biden-era ...

A "blanket" approach to environmental laws will restrict the ability for farmers to appropriately manage their land, a cattle producer says. Many producers rely on clearing of native trees to manage ...

Baricitinib showed significant hair regrowth in adolescents with severe alopecia areata, with 71% achieving successful scalp regrowth at 52 weeks on a 4 mg dose. The study highlighted the importance ...

A cure for baldness could be on the horizon. Researchers from Taiwan University say they have discovered a serum that could potentially regrow hair in just 20 days. The study, published in the journal ...

At 1 year, results showed 45.1% of patients receiving baricitinib 4mg and 31% of patients receiving baricitinib 2mg achieved successful hair regrowth (SALT ≤20). Long term data were announced from a ...

It’s a privilege to age—and hit menopause. But, with that, comes not just more wrinkled skin and hormonal acne, mood swings and dryness down there, but also another concern that impacts over 50 ...

As open enrollment approaches, a variety of factors — including pricey GLP-1 weight-loss drugs — are poised to push already expensive premiums for employer-sponsored healthcare even higher in 2026, a ...

A new oral drug stands to become the first prescription pill specifically designed to regrow hair in both women and men. If approved following current Phase 3 trials, it would be the first new ...